RAC1 and neoplasm: Even so, other therapeutical strategies have been used to treat tumours bearing this signature, such as: preventing RAC1 localization at the plasma membrane, hampering GTP binding, blocking GEF/RAC1 interaction or targeting its effector molecules (Figure 2, Table 1) [10].